Unusual ocular manifestations of ethomoidal mucocele: a case report / Manifestações oculares incomuns de mucocele etmoidal: relato de caso

ABSTRACT A 42-year-old female patient had vision loss and chronic epiphora in her left eye. Her best-corrected visual acuity was 10/10 in the right eye and 0.3/10 in the left eye. The anterior segment examination results were normal. In fundus examination, choroidal folds were detected. Optical coherence tomography showed elevation on the macula and choroidal folds. Ultrasonography revealed a T-sign. Magnetic resonance imaging revealed an ethmoidal mucocele that compresses the orbital tissues. Surgical treatment was performed in the otorhinolaryngology department. Postoperatively, choroidal folds recovered, and the best-corrected visual acuity improved, but subretinal fluid accumulated. During the follow-up period without any treatment, subretinal fluid totally disappeared.

RESUMO Paciente do sexo feminino, 42 anos, com perda visual e epífora crônica no olho esquerdo. Sua acuidade visual melhor corrigida foi de 10/10 no olho direito e 0,3/10 no olho esquerdo. O exame do segmento anterior foi normal. No exame de fundo de olho, foram detectadas pregas coroidais. A tomografia de coerência óptica revelou elevação na mácula e pregas coroidais. A ultrassonografia revelou sinal T. A imagem de ressonância magnética mostrou mucocele etmoidal que comprime os tecidos orbitários. O Departamento de Otorrinolaringologia realizou o tratamento cirúrgico. No pós-operatório, as dobras coroidais se recuperaram, a acuidade visual melhor corrigida foi melhorada, mas ocorreu líquido sub-retiniano. Durante o período de acompanhamento sem qualquer tratamento, o líquido sub-retiniano recuperou-se totalmente.

Maculopatía paracentral aguda media y neurorretinopatía macular aguda

La neurorretinopatía macular aguda es una condición rara con patogenia microvascular. Se presenta con un inicio agudo con escotomas paracentrales correspondientes a lesiones paramaculares evidentes. Los avances en las imágenes multimodales permitieron caracterizar este trastorno de retina y crear nuevos conceptos. Serraf, en el 2013, identificó dos formas por medio de la tomografía de coherencia óptica dominio espectral: el tipo 1 conocido como maculopatía paracentral aguda media en la cual se observa una banda hiperreflectiva en la capa nuclear interna, y el tipo 2 en el cual la banda hiperreflectiva se ubica en la capa nuclear externa, que involucra la zona elipsoide y la zona de interdigitación con el epitelio pigmentario de la retina. Hasta el momento no existe cura; pero se puede actuar sobre los factores de riesgo. Por ser una condición rara y por no existir reportes hasta el momento en Cuba es que se presentan a continuación dos pacientes con cuadros clínicos similares de estas dos variantes; concluyendo la importancia que presentan las imágenes multimodales como medio auxiliar diagnóstico.

Acute macular neuroretinopathy is a rare condition with complex pathogenesis and microvascular cause. It appears with acute onset, with paracentral scotomas corresponding to obvious paramacular lesions. Advances in multimodal imaging made it possible to characterize this retinal disorder and to create new concepts. Serraf, in 2013, identified two forms by spectral domain optical coherence tomography: type 1, known as paracentral acute middle maculopathy, in which a hyperreflective band is observed in the inner nuclear layer; and type 2, in which the hyperreflective band is located in the outer nuclear layer, involving the ellipsoid zone and the zone of interdigitation with the retinal pigment epithelium. Up to this moment, there is no cure; but it is possible to act on the risk factors. Because it is a rare condition and because there are no reports so far in Cuba, two patients with similar clinical pictures of these two variants are presented; concluding the importance of multimodal images as an auxiliary diagnostic tool.

Maculopatía por inmunoganmapatía

La maculopatía por inmunoganmapatía es una enfermedad macular inusual caracterizada por la presencia de fluido intra y subretinal en asociación con ganmapatías monoclonales. Puede constituir la primera manifestación de enfermedad sistémica en un número considerable de pacientes. La infiltración de la retina neurosensorial y del espacio subretiniano por las inmunoglobulinas provoca un aumento de la presión osmótica lo cual genera acumulación del fluido intra y subretinal. El "silencio angiográfico" la distingue de otras maculopatías con desprendimientos serosos. La plasmaféresis combinada con quimioterapia constituye la primera línea del tratamiento. Aunque el líquido intrarretinal mejora considerablemente, el subretinal persiste en la mayoría de los ojos. La agudeza visual mejor corregida final muestra una ganancia de 0,3 décimas como promedio después del tratamiento. Con el objetivo de exponer contenido actualizado sobre maculopatía por inmunoganmapatía, se realizó una revisión de las publicaciones más relevantes relacionadas con el tema durante los últimos ocho años.

Immunoganmapathy maculopathy is an unusual macular disease characterized by the presence of intra- and subretinal fluid in association with monoclonal ganmapathies. It may constitute the first manifestation of systemic disease in a considerable number of patients. Infiltration of the neurosensory retina and the subretinal space by immunoglobulins causes an increase in osmotic pressure which leads to accumulation of intra- and subretinal fluid. The "angiographic silence" distinguishes it from other maculopathies with serous detachment. Plasmapheresis combined with chemotherapy is the first line of treatment. Although intraretinal fluid improves considerably, subretinal fluid persists in most eyes. The final best-corrected visual acuity shows a gain of 0.3 tenths on average after treatment. In order to expose updated content on immunoganmopathy maculopathy, a review of the most relevant publications related to the subject during the last eight years was performed.

Laser cutting machine-induced maculopathy and spontaneous recovery / Maculopatia induzida por máquina de corte a laser e recuperação espontânea

ABSTRACT The thermal effects of laser cutting machines could damage the macula. A few studies in the literature have described macular injury induced by industrial laser burns. The aim of this study was to report the clinical, visual, and optical coherence tomography findings in a gold refinery worker with laser-induced maculopathy. A 21-year-old male gold refinery worker had vision loss in his right eye after using a laser cutting machine without wearing laser eye protection gear. At the first visit (24 h later), his best-corrected visual acuity was 7/10 in the right eye and 10/10 in the left eye. The anterior segment examination was normal. In fundus examination, focal, round, and yellowish lesion was detected within the fovea. The optical coherence tomography findings were foveal outer retinal disruptions and irregularities extending from the outer plexiform layer to the retina pigment epithelium. After 4 months, the best-corrected visual acuity had improved to 1.0, and the optical coherence tomography findings had resolved.

RESUMO Os efeitos térmicos das máquinas de corte a laser podem danificar a mácula. Poucos estudos na literatura tem descrito a lesão macular por queimadura a laser industrial. Neste estudo, objetivamos relatar os achados clínicos, visuais e de tomografia de coerência óptica em um trabalhador de refinaria de ouro com maculopatia induzida por laser. O trabalhador da refinaria de ouro de 21 anos teve perda de visão no olho direito depois de usar uma máquina de corte a laser sem usar equipamento protetor ocular para laser. Sua acuidade visual melhor corrigida foi de 7/10 no olho direito e 10/10 no olho esquerdo na primeira consulta (24h depois). O exame do segmento anterior estava normal. No exame de fundo de olho, lesões focais, redondas e amareladas foram detectadas dentro da fóvea. Os achados da tomografia de coerência óptica revelaram rupturas na fóvea da retina externa e irregularidades estendendo-se da camada plexiforme externa ao epitélio pigmentar da retina. Após 4 meses, a acuidade visual melhor corrigida melhorou para 1,0 e os achados da tomografia de coerência óptica foram revigorados.

Maculopatía en ojo de buey por uso de cloroquina. Presentación de un caso / Maculopathy in bull's eye due to the use of chloroquine. Presentation of a case

RESUMEN Se reportó el caso de un paciente con maculopatía en ojo de buey, asociada al uso de cloroquina. El uso de cloroquina en patologías reumatológicas puede provocar daño retinal relacionado con la dosis y el tiempo de evolución del tratamiento. Puede provocar desde afectación visual leve hasta daño irreversible de la visión, lo que depende del tiempo en que se realice el diagnóstico. Se presentó una paciente de 72 años, con diagnóstico de artritis reumatoide desde hace 21 años y tratamiento con cloroquina desde hace 15. Acudió a consulta con disminución de la visión lenta y progresiva bilateral. En el examen oftalmológico de fondo de ojo se diagnosticó maculopatía en ojo de buey. Este diagnóstico se confirmó por estudios de autofluorescencia y por la tomografía de coherencia óptica (AU).

ABSTRACT A case is reported of a patient with maculopathy in bulls' eye associated to the use of chloroquine. The use of chloroquine associated with rheumatologic diseases can cause retinal damage related to the dose and the time of treatment evolution. It can cause from mild visual impairment to irreversible vision damage depending on the time the diagnosis is made. A 72-year-old female patient is presented with a diagnosis of rheumatoid arthritis for 21 years and treatment with chloroquine for 15 years. She assisted the consultation with a slow and progressive bilateral vision decrease; at the ophthalmological examination of the fundus a maculopathy in bull's eye was diagnosed, later confirmed by auto fluorescence and optical coherence tomography studies (AU).

Inyección de gas intravítreo combinada con fotocoagulación con láser de argón para el tratamento de la maculopatía de la foseta del disco óptico sin vitrectomía / Intravitreal gas injection combined with argon laser photocoagulation for treatment of optic disc pit maculopathy without vitrectomy

RESUMEN Presentamos el caso de un paciente con foseta del disco óptico, quien presentó una disminución de la agudeza visual secundaria a desprendimiento seroso de retina. Se decidió realizar una inyección intravítrea de 0.3ml de gas C3F8 (100%), seguida de fotocoagulación con láser de argón en el borde temporal de la foseta, logrando reaplicación total de la retina, con reabsorción de todo el líquido subretiniano visible en la tomografía de coherencia optica (OCT) luego de 400 días. Además hubo una mejoría significativa en la agudeza visual.

ABSTRACT We present the case of a patient with an optic disk pit, presenting with great loss of visual acuity secondary to serous retinal detachment. The management chosen was an intravitreal injection of 0.3 mL of C3F8 (100%), followed by argon laser photocoagulation on the temporal edge of the pit, ), achieving total retinal reattachment , and reabsorption of all subretinal fluid visible at optical coherence tomography after 400 days, in addition to great improvement in visual acuity.

Caracterización clínica y epidemiológica de la maculopatía diabética en adultos de 50 años y más en Cuba / Clinical and epidemiological characterization of diabetic maculopathy in adults aged 50 years and over in Cuba

RESUMEN Objetivo: Determinar las características clínicas y epidemiológicas de la maculopatía diabética en adultos de 50 años y más en Cuba. Métodos: Se realizó una investigación epidemiológica, descriptiva transversal, que tomó la Encuesta Rápida de Ceguera Evitable realizada en Cuba en el año 2016, la cual incluyó la retinopatía diabética validada por la Organización Mundial de la Salud. Resultados: La prevalencia de cualquier grado de maculopatía fue de 8,5 por ciento (6,1 a 10,8) y la maculopatía observable y remitible fue de 4,2 por ciento (2,2 a 6,0). El riesgo de desarrollar maculopatía resultó mayor en el sexo femenino, con el 9,3 por ciento (6,6-12,9), y en los diabéticos que tenían entre 60 y 69 años de edad, de 9,2 por ciento (5,7-14,0). Este riesgo se incrementaba si existía descontrol de la glicemia y si la enfermedad tenía 15 años y más de evolución. La asociación con la retinopatía observable fue de 2,5 por ciento. La discapacidad visual moderada por maculopatía fue de 1,4 % y la grave junto con la ceguera de 0,8 por ciento. La cobertura de tratamiento fue baja (28,6 por ciento por personas). Conclusiones: El diabético de 50 años y más en Cuba tiene baja prevalencia de maculopatía diabética, la cual se comporta de manera similar para la forma observable y para la remitible. La retinopatía no proliferativa moderada tiene mayor riesgo de afectación macular. La discapacidad visual por afectación macular en el diabético es baja, aunque la estrategia de atención oftalmológica en el diabético no alcanza los estándares necesarios de efectividad, relacionados con la cobertura del tratamiento con láser(AU)

ABSTRACT Objective: Determine the clinical and epidemiological characteristics of diabetic maculopathy in adults aged 50 years and over in Cuba. Methods: A descriptive cross-sectional epidemiological study was conducted based on the Rapid Assessment of Avoidable Blindness survey developed in Cuba in the year 2016, which included diabetic retinopathy with validation by the World Health Organization. Results: Prevalence of any maculopathy grade was 8.5 percent (6.1 to 10.8), whereas observable, referable maculopathy was 4.2 percent (2.2 to 6.0). Risk for maculopathy was higher in the female sex with 9.3 percent (6.6-12.9) and among diabetics from the 60-69 years age group with 9.2 percent (5.7-14.0). Risk increased in uncontrolled glycemia and when the evolution of the disease was 15 years and over. Association with observable retinopathy was 2.5 percent. Moderate visual disability due to maculopathy was 1.4 percent, while severe disability and blindness were 0.8 percent. Treatment coverage was low (28.6 percent per persons). Conclusion: Prevalence of maculopathy is low among diabetics aged 50 years and over in Cuba, with similar behavior in the observable and the referable variants. Moderate non-proliferative retinopathy shows a higher risk for macular damage. Visual disability due to macular damage is low among diabetics, though the ophthalmological care strategy for diabetics does not achieve the required effectiveness standards in terms of laser therapy coverage(AU)

Complicaciones oculares asociadas a la fiebre por dengue / Ophthalmic complications associated to dengue fever

RESUMEN La infección por el virus del dengue va en aumento en las regiones tropicales de Asia, África y América. Se estima que se producen de 50 a 100 millones de casos de esta enfermedad al año. En los últimos tiempos han aumentado los reportes de manifestaciones oculares en estos pacientes, las cuales ocurren en un rango de 5 a 7 días posteriores al inicio de los síntomas, aunque también pueden ocurrir más tarde, y generalmente existe buen pronóstico visual. Se realiza una revisión bibliográfica con el objetivo de ampliar el conocimiento sobre un tema poco tratado en nuestro medio. Se consultaron fundamentalmente artículos científicos de revistas, publicados en las bases de datos PubMED y Cochrane, así como textos básicos que abordan este tema en los últimos 5 años, a través de Google académico como motor de búsqueda. Se constató que se han reportado manifestaciones oculares en pacientes con dengue que van desde hallazgos en el segmento anterior sin afectación visual, hasta cuadros más intensos que interesan las estructuras del polo posterior del ojo. La fisiopatología de estos hallazgos aún se encuentra en estudio y no existe consenso para su tratamiento. A pesar de que el pronóstico visual de estas alteraciones es bueno, se reportan casos donde no es así y se precisa mayor comprensión sobre la fisiopatología de estas para un abordaje terapéutico más adecuado en cada caso(AU)

ABSTRACT Infection by dengue virus is on the increase in tropical regions of Asia, Africa and America. It has been estimated that 50 to 100 million cases of this disease occur every year. Recent years have witnessed a rise in the number of reports of ocular manifestations in dengue patients. These manifestations appear 5 to 7 days after symptom onset, though they could also occur later, and the visual prognosis is generally good. A bibliographic review was conducted with the purpose of broadening knowledge about a topic not commonly dealt with in our environment. The search was mainly aimed at scientific papers from journals, published in the databases PubMed and Cochrane, as well as basic texts addressing the study topic in the last 5 years, using the search engine Google Scholar. Ocular manifestations were found to have been reported in dengue patients. These range from findings in the anterior segment without any visual alteration to more intense episodes affecting the structures of the posterior pole of the eye. The physiopathology of these findings is still being studied, and there is no consensus about its treatment. Despite the good visual prognosis of these alterations, cases have been reported of a different outcome. Therefore, a better understanding is required of their physiopathology to achieve a more appropriate therapy for each case(AU)

Maculopatía media paracentral aguda: a propósito de un caso y revisión de la literatura / Paracentral acute middle maculopathy: a clinical case report and review of the literature

Introducción: la maculopatía media paracentral aguda (PAMM) es una entidad descrita en la tomografía de coherencia óptica de dominio espectral (SD-OCT). Se caracteriza por la presencia de una banda hiperrefringente de localización parafoveal en las capas medias retinales y se manifiesta por la aparición de escotomas paracentrales. En este artículo se presenta un caso clínico con el diagnóstico de PAMM y una breve revisión de la literatura. Métodos: se solicitó consentimiento informado escrito del paciente bajo la aprobación del comité ético-cien-tífico de la Facultad de Medicina de la Pontificia Universidad Católica de Chile. La revisión de la literatura se realizó mediante una estrategia de búsqueda que incluyó los términos explicitados en las palabras clave. Resultados: el paciente consulta por un escotoma paracentral superior en el ojo derecho (OD). En la autofluorescencia se observó una lesión hipoautofluorescente parafoveal inferior del OD. La angiografía retinal mostró tenue filtración en la misma zona, sin signos de oclusión arterial. En la SD-OCT del OD, se observó una lesión hiperrefringente parafoveal inferior en las capas medias retinales. El estudio sistémico descartó causas infeccioso-inflamatorias y vasculares. A partir de lo anterior, se realizó el diagnóstico de PAMM. Conclusiones: la presentación clínica y los resultados obtenidos fueron concordantes con lo reportado en la literatura respecto a la PAMM. Actualmente el manejo se basa en buscar y controlar condiciones relacionadas, puesto que no se ha descrito tratamiento específico. En este caso, se descartaron causas secundarias y se decidió la observación clínica.

Background: Paracentral acute middle maculopathy (PAMM) refers to a recently discovered finding described in the field of spectral-domain optical coherence tomography (SD-OCT). The main hallmark of PAMM is a hyper-reflective band-like lesion involving the middle layers of the retina in a parafoveal position. Typically, patients present with an acute onset of paracentral scotomas. In this article, we report a clinical case of PAMM and a brief review of the relevant literature. Methods: To obtaining clinical information, the requirements included a written informed consent form and the approval of the Ethical-Scientific Committee of Pontificia Universidad Católica de Chile. The literature review was carried out using a search strategy that included the terms specified in the keywords. Results: The patient presented an acute history of a superior paracentral scotoma in the right eye (RE). Fundus autofluorescence uncovered a hypo-autofluorescent area at the inferior fovea in the RE. Fluorescein angiography excluded a retinal artery occlusion and showed a hyperfluorescent capillary leakage at the same location. SD-OCT revealed a hyper-reflective band-like lesion in the middle retinal layers. A complete search for infectious, inflammatory, and vascular causes ruled out secondary conditions. These results were consistent with a diagnosis of PAMM. Conclusions: Clinical presentation and laboratory findings were compatible with the actual evidence concerning PAMM. The current management consists of identification and treatment of related vascular and systemic associated factors because there is no specific treatment for this condition. In this case, a negative study of secondary aetiologies supported the decision of clinical observation.

Maculopatia solar após o uso de LSD: relato de caso / Solar maculopathy after LSD use: a case report

Introdução: A maculopatia ou retinopatia solar é uma lesão foto-traumática da mácula causada pela observação direta ou indireta de fontes luminosas intensas, que ocorre comumente na presença de distúrbios psíquicos ou após o uso de drogas recreativas. O prognóstico visual varia e a conduta é expectante. Descrição do caso: Paciente V.V.A.M., sexo masculino, 20 anos, estudante, com queixa de escotoma central em ambos os olhos. Nega antecedentes patológicos e oculares. Solicitaram-se tomografia de coerência óptica (OCT) e retinografia, que revelaram uma lesão central, bilateral e simétrica na retina externa. Paciente relatou ter feito uso de Dietilamida de ácido lisérgico (LSD) e, sob influência da droga, ter olhado de forma direta para o sol por aproximadamente 40 minutos. Discussão: O prognóstico da retinopatia solar é variável e relaciona-se com o tempo de exposição e com o comprimento da onda da fonte de luz. A etiopatogênese é explicada pelo dano causado ao epitélio pigmentar da retina (EPR) pela radiação. Conclusões: Deve haver maior orientação ao público sobre os possíveis efeitos danosos de exposição a fontes de luz de origens diversas. Além disso, destaca-se a importância do OCT para a identificação da maculopatia solar. (AU)

Introduction: Solar maculopathy or retinopathy is photo-traumatic damage created on the macula, caused by direct or indirect observation of intense light sources, commonly occurring in the presence of psychic disorders or after the use of recreational drugs. The visual prognosis varies. There is currently no known treatment. Case report: A 20-year-old male with no previous complaints reported central scotoma in both eyes despite 20/20 uncorrected vision. Bilateral, symmetric, central changes could be seen in the macula in fundoscopy. Optical coherence tomography (OCT) confirmed loss of the external retina suggestive of Solar Maculopathy. The patient later claimed to have spent 40 minutes looking directly into the sun after use of Lysergic Acid Diethylamide (LSD). Discussion: The prognosis of solar retinopathy is related to the exposure time and to the wavelength of the light source, with those between 300-350 nm being the most harmful. Its etiopathogenesis is explained by damage caused to the retinal pigment epithelium (EPR) caused by radiation, interrupting the interdigitations between this layer and the external segment of the photoreceptors. Ophthalmoscopically, solar maculopathy is characterized by a small foveolar lesion that might become yellowish in the days following exposure, in the form of exudate or edema, followed by loss of foveal reflex and thinning of the fovea. The initial yellowed lesions are subsequently replaced by a spotted EPR or even by a lamellar orifice. Conclusions: There should be public guidance on the possible harmful effects of exposure to sources of light from diverse origins, as it usually occurs during solar eclipses, after exposure to certain types of lasers or observation of fires since this habit can cause severe and sometimes irreversible visual loss. (AU)

Desprendimiento seroso macular asociado a fosetas papilares tratado con fotocoagulación / Serous macular detachment associated to optic disc pits treated with photocoagulation

Las fosetas congénitas papilares son poco comunes. Se trata de una entidad caracterizada típicamente por depresiones papilares unilaterales, ovales, de color blanco grisáceo. Reportamos un caso con dicha entidad asociada al desprendimiento seroso tratado con fotocoagulación. Se realizó un estudio descriptivo a una paciente femenina de 14 años quien refirió pérdida de visión del ojo izquierdo de un mes de evolución. Se realizó fotocoagulación láser al borde yuxtapapilar temporal de la foseta, con evoluciones al mes y a los 3, 6, 9, 12 y 24 meses posteriores, mediante tomografía de coherencia óptica, mejor agudeza visual corregida y oftalmoscopia. Se logró progresiva disminución del desprendimiento macular y mejoría de la agudeza visual desde el primer mes de control. A los 9 meses se observó normal arquitectura macular en la tomografía de coherencia óptica y mejoría de la agudeza visual a 20/25 (95 VAR), con iguales resultados en los controles a los 12 y 24 meses. La terapéutica con fotocoagulación puede resultar eficiente, simple, mínimamente invasiva y económica para la maculopatía asociada a la foseta papilar(AU)

Congenital optic disc pits are an infrequent condition typically characterized by unilateral oval grayish-white papillary depressions. A case report is presented of this condition associated to serous detachment treated with photocoagulation. A descriptive study was conducted of a 14-year-old female patient who reported loss of vision in her left eye with a month of evolution. Laser photocoagulation was performed on the temporal juxtapapillary edge of the pit, with evolution checks at 3, 6, 9, 12 and 24 months by optical coherence tomography, best corrected visual acuity and ophthalmoscopy. Progressive macular detachment reduction and visual acuity improvement were observed since the first control. At 9 months optical coherence tomography showed a normal macular architecture and visual acuity improvement to 20/25 (95 VAR) with identical results at 12 and 24 months. Photocoagulation therapy may be efficient, simple, minimally invasive and economical for maculopathy associated to optic disc pits(AU)

Estudio sobre la prevención de la discapacidad visual en pacientes diabéticos del municipio Playa / Study on the prevention of visual disability in diabetic patients from Playa municipality

Objetivo: determinar el comportamiento de la discapacidad visual por retinopatía diabética en dos áreas de salud del municipio Playa. Métodos: se realizó una investigación exploratoria, observacional y descriptiva, en la que se practicó un examen oftalmológico a los diabéticos, donde se evaluó por especialistas de retina la presencia de lesiones en el fondo de ojo y su asociación con otras afecciones oftalmológicas. Resultados: las dos áreas de salud presentaron características demográficas y de la enfermedad diabética similares. Las formas no proliferativas de los dos grupos se presentaron en el 8,5 y 4,8 por ciento, no así la forma proliferativa, que fue de 2 y 2,7 por ciento. La maculopatía leve fue más frecuente que la severa en los dos grupos. La prevalencia de algún grado de retinopatía y de maculopatía fue de 13,1 y 10,6 por ciento, respectivamente. El mayor porcentaje de pacientes en los dos grupos de estudio no había sido examinado o había transcurrido más de un año de haberse realizado un fondo de ojo. Se encontró un número elevado de ojos de pacientes con catarata evidente (31,2 y 26,5 por ciento. La prevalencia de baja visión (10,9 y 11 por ciento) y de ceguera (2,9 y 2,7 por ciento) fue similar en los dos grupos, pero sus causas pueden ser reversibles, prevenibles y tratables. Conclusiones: a pesar de que la muestra fue pequeña y la prevalencia de retinopatía y/o maculopatía fue baja, se presentaron pacientes con discapacidad visual prevenible y tratable(AU)

Objective: to determine the situation of visual disability caused by diabetic retinopathy in two health areas of Playa municipality. Methods: a descriptive, observational and exploratory research study was conducted where eye exam was performed in diabetic patients to evaluate the presence of fundus oculi lesions and their association with other ophthalmological diseases. Results: it was found that the two health areas showed similar demographic characteristics and diabetic disease features. Non-proliferative forms of the two groups occurred in 8.5 and 4.8 percent whereas the proliferative form was seen in 2 percent and 2.7 percent. Mild maculopathy was more common than the severe one in the two groups of patients. The prevalence of retinopathy and maculopathy was 13.1 and 10.6 percent, respectively. The highest percentage of patients in the two study groups had not been examined or their fundus oculi test had been performed over a year ago. There was a high number of patients with evident cataract (31.2 and 26.5 percent). The prevalence rates of low vision (10.9 and 11 percent) and of blindness (2.9 and 2.7 percent) were almost the same in the two groups; however it should be borne in mind that their causes can be reversible, preventable and treatable. Conclusions: despite the small sample size and the low prevalence of retinopathy and/or maculopathy, there were patients with preventable and treatable vision(AU)

Manifestaciones retinianas secundarias a Dengue. Reporte de caso / Retinal manifestations after Dengue fever. A case report

Introducción: El Dengue es una infección viral aguda, causada por un virus de la familia Flaviviridaeque se transmite por la picadura del mosquito Aedes Aegypti. Se han descrito manifestaciones oculares asociadas a esta enfermedad como son: maculopatía, hemorragias retinales, neuritis óptica, retinitis y vasculitis, aunque son poco frecuentes. Objetivo: Presentar un caso con manifestaciones oculares después de ser diagnosticado con Dengue. Presentación del caso: Paciente masculino de 58 años de edad que 1 mes después de haber padecido Dengue comienza a presentar visión borrosa en ambos ojos, constatándose al examen oftalmológico del fondo de ojo, hemorragias maculares y exudados escasos en algunos cuadrantes en ambos ojos. Recibió tratamiento con antiinflamatorios sistémicos por 2 meses y mejoró su sintomatología inicial, así como el cuadro clínico fondoscópico. Conclusiones: El Dengue es una enfermedad con repercusión no solo sistémica sino también oftalmológica lo que, aunque no es muy frecuente, debe tenerse presente. Resultaron de considerable utilidad la clínica, la retinofoto y la tomografía de coherencia óptica (OCT) para el seguimiento de las alteraciones retinianas halladas posterior a su aparición. Los esteroides fueron utilizados con éxito para el tratamiento en este caso(AU)

Introduction: Dengue is an acute viral infection, caused by a virus of flaviviridae family that is transmitted by the Aedes Aegypti mosquito sting. Ocular manifestations associated to this illness have been described such as maculopathy, retinal hemorrhages, optic neuritis, retinitis and vasculitis, although they are not frequent. Objective: To present a case that is not frequently reported in own context. Case presentation: 58-year-old male patient that suffered from dengue and 1 month after that he began having blurred vision in both eyes. In the ophthalmic examination, it was detected that he had macular hemorrhages and exudates in some quadrants of both eyes. He was treated with systemic antiinflammatories for 2 months. There was an improvement of his initial symptoms and the clinical features of the ocular fundus with this treatment. Conclusions: Dengue is an illness that has not only a systemic impact but also causes ophthalmic damage that we should consider. The clinical manifestations, the retinophoto and the optical coherence tomography (OCT) were considerably useful for the follow-up of the retinal alterations found post-dengue. Steroids were used successfully for the treatment of this case(AU)

Optical coherence tomography and congenital retinoschisis: three case reports / Tomografia de coerência óptica e retinosquise congênita: relato de três casos

Abstract Congenital retinoschisis is an X-linked recessive inherited disease. It causes the splitting of the retina's neurosensory layers from the remaining of the sensory retina, presenting itself as a "stellate" or "bicycle-wheel" maculopathy, vitreous hemorrhage and retinal detachment. We report three cases of congenital retinoschisis, two of them brothers. optical coherence tomography was used when evaluating the cases. It was impossible to differentiate retinoschisis from retinal detachment in one of the cases through optical coherence tomography due to lack of patient collaboration. We then performed laser photocoagulation to mark and follow-up the affected area.

Resumo A retinosquise congênita é uma doença autossômica recessiva ligada ao X. Resulta em separação da camada de fibras nervosas do restante da retina sensorial, e manifesta-se como maculopatia estriada, hemorragias vítreas e descolamento de retina. Relatamos três casos de retinosquise congênita, sendo dois deles irmãos. Utilizou-se a tomografia de coerência óptica na avaliação dos casos. Em um, não foi possível efetuar o diagnóstico diferencial com descolamento de retina através da tomografia de coerência óptica, devido a não cooperação no exame, optando-se pela realização de fotocoagulação com laser para demarcação e seguimento da área.

Maculopatía relacionada con la foseta del nervio óptico / Optic nerve head pit-associated maculopathy

Se realizó una revisión bibliográfica con el objetivo de ampliar el conocimiento sobre la maculopatía relacionada con la foseta del nervio óptico, su fisiopatología, así como sus principales manifestaciones, diagnóstico clínico, angiográfico y por tomografía de coherencia óptica, y describir algunos de los tratamientos que se han utilizado recientemente a nivel mundial. Se tuvieron en cuenta las tendencias actuales de tratamiento. Se consultaron fundamentalmente artículos científicos de revistas publicados en las bases de datos PubMED y Cochrane, así como textos básicos que abordan este tema en los últimos 5 años, a través de Google como motor de búsqueda. A pesar de que se trata de una enfermedad infrecuente, su manejo suele resultar difícil, especialmente cuando existe afectación macular. En nuestro trabajo constatamos que la mayoría de los estudios utilizan muestras pequeñas, son retrospectivos, no comparativos y no ramdomizados. Sin embargo, se encontraron modalidades de tratamiento que han sido utilizadas por años y más recientemente descripciones de nuevas técnicas que requerirán futuros estudios. No existe un consenso sobre un protocolo ideal de tratamiento para esta entidad(AU)

A literature review was made to expand knowledge on the optic nerve head pit-related maculopathy, its physiopathology and main manifestations, clinical and angiographic diagnosis, optical coherence tomography, and to describe some of the treatments recently used worldwide. The current therapeutic tendencies were taken into account. The fundamental sources of information were scientific articles from journals in PubMED and Cochrane databases as well as basic texts which dealt with this topic in the last five years through Google search engine. Despite the rare occurrence of the disease, its management may be difficult particularly in macular effect cases. This paper confirmed that most of the studies used small samples, were retrospective, non-comparative and non-randomized. However, some therapeutic modalities were found, which have been used for years and also descriptions of new techniques that require further research. There is no consensus on the ideal treatment protocol for this disease(AU)

Efeitos colaterais oculares dos antimaláricos / Antimalarial ocular side effects

Introdução: A cloroquina e a hidroxicloroquina são medicamentos amplamente utilizados para tratamento das doenças do tecido conjuntivo como artrite reumatóide, lúpus eritematoso sistêmico, Síndrome de Sjögren e osteoartrite mãos. Seus efeitos colaterais mais temidos são os oculares: depósitos corneais e retinopatia. Material e métodos: Foram estudados os prontuários dos pacientes portadores de artrite reumatoide do ambulatório de reumatologia do Hospital Evangélico de Curitiba e usuários de antimaláricos (total de 167) para alterações oculares secundárias ao medicamento. Resultados: Em 5 pacientes existia diagnóstico de maculopatia e em 4 o diagnóstico de ceratopatia por cloroquina, com associação positiva para idade avançada e com tempo de uso. Conclusão: A ceratopatia e maculopatia por antimaláricos ocorreram em pequena proporção de usuários de cloroquina (2,4% e 3% respectivamente), não sendo encontrado este efeito adverso nos usuários de hidroxicloroquina.

Chloroquine and hydroxychloroquine are widely used drugs indicated for treatment of connective tissue diseases such as rheumatoid arthritis, systemic lupus erythematosus, Sjogren´s syndrome and hand osteoarthritis. The most feared side effects of these medications are corneal deposits and maculopathy. Material and methods: We reviewed the charts of 167 patients with rheumatoid arthritis from rheumatology unit of Hospital Evangélico de Curitiba for ocular side effects of this medication. Results: There was maculopathy in 5 patients using chloroquine and in 4 of them, there was ceratopathy. This finding had a positive association with older age and prolonged use of this medication. Conclusions: Antimalarial cerathopathy and maculopathy occurred in a small proportion of cloroquine users (2,4 and 3% respectively). These side effects weren't found in hydroxylchlroquine patients.

Maculopatía tóxica por cloroquina y rehabilitación visual mediante microperímetro MP1 / Phacoemulsification in the treament of iridocorneal endothelial syndrome

La cloroquina es un fármaco que puede producir disfunciones visuales, baja visión e incluso ceguera según la dosis. Una dosis acumulativa menor a 100 g de cloroquina, o una duración de tratamiento de menos de un año raramente se asocia con lesión retiniana. El riesgo de toxicidad aumenta cuando la dosis acumulativa excede los 300 g (250mg/día durante 3 años). Este medicamento es utilizado en el tratamiento de enfermedades autoinmunes. Se presenta una paciente de 44 años de edad, con antecedentes de artritis reumatoide hace 14 años para lo cual se indicó tratamiento con cloroquina (1 tableta 250 mg/diaria) desde el diagnóstico inicial, y presenta un diagnóstico de maculopatía por cloroquina hace 5 años, a consulta por presentar baja visión y solicitando una posibilidad de rehabilitación visual. Se realizó examen oftalmológico, estudios complementarios y se rehabilitó mediante el microperímetro MP1. Se concluye que la maculopatía por cloroquina es una de las causas de discapacidad visual y que la rehabilitación visual con microperimetría proporciona mejoría en varios parámetros visuales, mejorando la calidad visual del paciente

Chloroquine-induced toxic maculopathy and visual rehabilitation through the use of microperimeter MP1.Chrloroquine is a drug that may cause visual dysfunctions, low vision and even blindness depending on dose. An accumulative dose lower than 100 g of chloroquine or a length of treatment less than one year is rarely associated to retinal injure. The toxicity risk increases when the accumulative dose exceeds 300 g (250mg/day for 3 years). This drug is used in treating autoimmune diseases. Here is the case of a 44 years-old patient, with history of rheumatoid arthritis for 14 years. Chloroquine treatment was indicated (one 250 mg tablet daily) at the time of initial diagnosis. Five years ago, he was diagnosed with chloroquine-induced maculopathy when he went to the doctor's because of low vision and asked for possible visual rehabilitation. An ophthalmologic exam, some supplementary studies and rehabilitation through the microperimeter MP1 were all performed. It was concluded that chloroquine-maculopathy with microperimetry provides improvement of several visual parameters and better visual quality for the patient

Maculopatía por cloroquina / Maculopathy from use of chloroquine

La toxicidad de la cloroquina está relacionada con la dosis. Una dosis acumulativa de -100 g de cloroquina o una duración del tratamiento de menos de 1 año raramente se asocia con lesión retiniana. El riesgo de toxicidad aumenta significativamente cuando la dosis acumulativa excede los 300 g (250/día por 3 años). Se presenta un paciente del sexo femenino, con antecedentes de lupus eritematoso sistémico, hace 17 años, para lo cual se le indicó un tratamiento con cloroquina, (1 tableta 250 mg/diaria) durante 15 años. Como síntoma capital presentaba disminución lenta y progresiva de la agudeza visual de 2 años de evolución; se le realizó un examen oftalmológico y otros exámenes complementarios que condujeron al diagnóstico de la enfermedad, y se estableció su tratamiento y su pronóstico. Se realizan recomendaciones.

Chloroquine toxicity depends on the dose. A cumulative dose of under 100 g of chloroquine or a length of treatment for less than one year is rarely associated to any retinal lesion. The toxicity risk significantly increases with the cumulative dose over 300 g (250 g/day for three years). The case of a female patient with a history of lupus erythematosus for 17 years was presented. She was treated with chloroquine (one 250 mg every day) for 15 years. The main symptom was slow and progressive reduction of visual acuity experienced for 2 years; a complete ophthalmologic exam and other supplementary tests were indicated, which led to a diagnosis of maculopathy, and treatment and prognosis were then presented. Recommendations were made.

Degeneración macular relacionada a la edad / Age-related macular degeneration

La degeneración macular relacionada a la edad es la causa más frecuente de pérdida de visión irreversible en personas mayores de 60 años. Son factores de riesgo la edad, la genética, el tabaquismo y la obesidad abdominal. Su primera manifestación visible son las drusas, acumulación de productos provenientes de la degradación incompleta de la digestión de segmentos de fotoreceptores por el epitelio pigmentario. La administración de antioxidantes y zinc disminuye el riesgo de pérdida severa de visión en un 25 por ciento en pacientes con drusas. El proceso puede evolucionar a la atrofia de fotoreceptores y epitelio pigmentario (forma seca) o a la aparición de vasos de neoformación que invaden el espacio subretinal, son sangre y líquido subretinal (forma húmeda). La primera es de comienzo insidioso y lentamente progresiva. La segunda produce pérdida brusca de visión central. No existe hoy día un tratamiento eficaz para la forma seca. La forma neovascular no tratada tiene un pobre pronóstico conduciendo a ceguera legal. Sin embargo, la terapia antiangiogénica con inyecciones intravitreas repetidas de bloqueadores del factor de crecimiento endotelial (VEGF) permite la estabilización o mejoría de visión en la mayoría de los pacientes

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in persons over 60 years of age. Risk factors are age, genetics, smoking and abdominal obesity. Drusen are the first visible sign of the disease, as yellow deposits lying deep in the retina. Drusen are accumulation of residual bodies due to incomplete digestion of the outer segments of the photoreceptors by the retinal pigment epithelium. In patients with drusen, the administration of antioxidants and zinc, reduces the risk of severe loss of vision by 25 percent. The disease may progress to atrophy of the retinal pigment epithelium ("dry AMD") or to a neovascular form, with invasion of the subretinal space by sprouts of coroidal neovascularization, with blood and subretinal fluid ("wet AMD"). The dry form is a slowly progressive disease, with patches of retinal pigment epithelium and photoreceptor atrophy. Patients with the wet form experience sudden loss of vision. There is no proven effective treatment for the dry form today. Neovascular AMD has a poor prognosis if left untreated, resulting in legal blindness. However, antiangiogenic therapy with anti-vascular endotelial growth factor modalities, administered in repeated intravitreal injections, allows stabilization or improvement of visual acuity in most cases.

Complicações oculares da terapêutica com a cloroquina e derivados / Ocular complications of chloroquine and derivatives therapy

INTRODUÇÃO: Os derivados das 4-aminoquinolonas vêm sendo utilizados desde sua industrialização na terapêutica da malária, das doenças reumatológicas e dermatológicas. Essas drogas apresentam reações adversas sistêmicas e oculares. As reações adversas sistêmicas afetam o sistema gastrointestinal, sistema nervoso, sistema muscular esquelético e a pele, e as oculares são: fotofobia, córnea verticilata, poliose, catarata, paralisia dos músculos extraoculares, uveíte anterior, maculopatia tóxica, neurite óptica. OBJETIVO: Revisão bibliográfica das complicações do uso de cloroquina e derivados. Analisar evolução e estágio atual da propedêutica. Sugerir conduta prática no mapeamento precoce dos sinais de toxicidade. MÉTODOS: Revisão bibliográfica através da pesquisa no banco de dados MEDLINE, PUBMED, LILACS e SciELO. DISCUSSÃO: São descritos todos os exames que podem ser utilizados para mapeamento das reações adversas oculares, tais quais: exame oftalmológico completo, com ênfase na biomicroscopia e oftalmoscopia binocular indireta, campo visual computadorizado, tela de Amsler, visão de cores, exames eletrofisiológicos, polarimetria e tomografia de coerência óptica. É feita a descrição do quadro de maculopatia enfocando epidemiologia, fatores de risco, histopatologia e propedêutica. É descrita a estrutura química e as diferenças entre os derivados das 4-aminoquinolonas. CONCLUSÃO: Todo paciente em uso de cloroquina e seus derivados devem ser acompanhados e documentados desde seu início e até atingir a dose cumulativa acima de 100 gramas. Quanto maior a dose cumulativa, maior deve ser a nossa preocupação com o seguimento desse paciente.

INTRODUCTION: Byproducts of 4-aminoquinolones are being used since its industrialization in the treatment of malaria, rheumatic and dermatologic diseases. These drugs present systemic and ocular adverse events. Systemic adverse reactions affect the gastrointestinal, nervous and skeletal muscular systems and the skin. Ocular adverse reactions are: photophobia, cornea verticillata, poliosis, cataract, extraocular muscle palsy, anterior uveitis, toxic maculopathy and optical neuritis. PURPOSE: Bibliography review of complications due to the use of chloroquine and its derivatives. To analyze the current practice and propedeutics' evolution. To suggest practical managements for early toxicity signs. METHODS: Bibliographic review through research on MEDLINE, PUBMED, LILACS and SciELO database. DISCUSSION: All exams that can be used to screen ocular adverse reactions are described, such as: complete ophthalmologic exam, with emphasis on biomicroscopy and indirect binocular ophthalmoscopy, computerized visual field, Amsler grid testing and color vision testing, electrophysiological exams, polarimetry and optical coherence tomography. A description of maculopathy is presented, focusing on epidemiology, risk factors, histopathology and propedeutics. Chemical structure and the differences between 4-aminoquinolone derivatives are described. CONCLUSION: All patients using chloroquine and its derivatives must be followed-up and documented since the beginning of the therapy until they reach a cumulative dose above 100 grams. The higher the cumulative dose, the more we must be concerned with patient follow-up.